What's Driving the Interventional Neuroradiology Market 2025-2034: Rising Neurological Disorders Fuel Market Growth

What Are the Projections for the Size and Growth Rate of the Interventional Neuroradiology Market?
In recent times, there has been significant growth in the size of the interventional neuroradiology market. This market is projected to expand from $1.94 billion in 2024 to $2.06 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. Factors contributing to the growth during the historical period include the increasing acceptance of catheter-based interventions, improvements in healthcare infrastructure, rising incidents of hypertension, growing prevalence of diabetes and the expansion of telemedicine.

The market size of interventional neuroradiology is predicted to experience significant expansion in the upcoming years, reaching $2.61 billion in 2029 with a compound annual growth rate (CAGR) of 6.0%. Factors contributing to this growth during the projected period include the introduction of a liquid embolic agent, the increasing use of endovascular treatments, an uptick in the usage of mechanical thrombectomy, a growing dependency on detachable embolic coils, and higher use of bioresorbable scaffolds. Key trends expected to shape this period include advancements in navigation systems, innovation in radiolucent support devices, the application of artificial intelligence in neuroimaging devices, improved thrombectomy devices, and the incorporation of artificial intelligence in interventional appliances.

What Are the Main Catalysts for Growth in the Interventional Neuroradiology Market?
The rise in the number of neurological disorders is predicted to fuel the expansion of the interventional neuroradiology market. These disorders, which can affect the brain, spinal cord, or peripheral nerves, can cause difficulties with movement, sensation, cognition, or communication. The increase in neurological disorders is due to a larger aging population worldwide, resulting in a higher risk of age-related diseases like Alzheimer's, together with advancements in diagnostic technology that facilitate the earlier and more precise identification of these disorders. Interventional neuroradiology uses minimally invasive techniques guided by imaging to diagnose and treat conditions such as aneurysms, strokes, and arteriovenous malformations. For example, Alzheimer's Research UK, a dementia research charity based in the UK, reported that dementia was the major cause of death in the UK in 2022, causing over 74,000 deaths (11.3% of all deaths), a rise of 5,000 from 2021. Hence, the increasing frequency of neurological disorders is stimulating the expansion of the interventional neuroradiology market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20853&type=smp

Which Businesses Are at the Forefront of Interventional Neuroradiology Market Development?
Major companies operating in the interventional neuroradiology market are Bayer HealthCare, Abbott Laboratories, Medtronic PLC, Siemens Healthineers AG, Fujifilm Corporation, Philips Healthcare, Stryker Corporation, GE Healthcare Life Sciences, Boston Scientific Corporation, Terumo Corporation, Canon Medical Systems Corporation, W. L. Gore & Associates Inc., Teleflex Incorporated, Cook Medical LLC, Biotronik SE & Co. KG, Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., Guerbet Group, Mediterra LLC, Acandis GmbH, Medico's Hirata Inc.

What Are the Emerging Trends in the Interventional Neuroradiology Industry?
Leading organizations in the interventional neuroradiology market are prioritizing the creation of cutting-edge solutions aiming to improve imaging quality and patient safety during interventional radiology and neuroradiology procedures. This includes head immobilizers, specifically designed to temporarily hold a patient's head and neck in a static position, essential for ensuring security and stability in case of potential head or spinal injuries. For example, Adept Medical, a medical device manufacturer based in New Zealand, released a novel head immobilizer in June 2023. This device was made to increase patient comfort and imaging quality during interventional radiology and neuroradiology operations. It consists of unique features like vacuum suction technology for reliable head fixation, a radiolucent design to avoid X-ray imaging disruption, and its compatibility with diverse imaging tables. Its efficient setup process optimizes workflow, and its capacity to adapt to varying head structures assures patient comfort.

How Is the Interventional Neuroradiology Market Segmented?
The interventional neuroradiology market covered in this report is segmented -

1) By Device Type: Microcatheters, Neurovascular Embolization And Coiling Assist Devices, Embolic Coils, Flow Diversion Devices, Liquid Embolic Agents, Accessories, Micro Guidewires
2) By Disease: Cerebral Aneurysms, Intra-Cranial Tumors, Acute Strokes, Other Diseases
3) By End Users: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers

Subsegments:
1) By Microcatheters: Single-Lumen Microcatheters, Dual-Lumen Microcatheters, High-Flow Microcatheters
2) By Neurovascular Embolization And Coiling Assist Devices: Coiling Assist Devices, Embolization Assist Devices
3) By Embolic Coils: Soft Coils, Stiff Coils, Detachable Coils
4) By Flow Diversion Devices: Stent-Based Flow Diversion Devices, Non-Stent-Based Flow Diversion Devices
5) By Liquid Embolic Agents: Polymer-Based Liquid Embolic Agents, Gel-Based Liquid Embolic Agents, Onyx Liquid Embolic Agents
6) By Accessories: Guide Catheters, Sheath Introducers, Vascular Access Devices
7) By Micro Guidewires: Hydrophilic Micro Guidewires, Pushable Micro Guidewires, Coated Micro Guidewires

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/interventional-neuroradiology-global-market-report

Where Is the Interventional Neuroradiology Market Growth Most Prominent?
North America was the largest region in the interventional neuroradiology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the interventional neuroradiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Interventional Neuroradiology Global Market Report?

- Market Size Analysis: Analyze the interventional neuroradiology Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the interventional neuroradiology Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the market.
- Market Contribution: Evaluate contributions of different segments to the overall interventional neuroradiology market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the interventional neuroradiology market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20853

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.